Mr Price sales surge with NKD purchase as earnings growth stays muted
Revenue jumped 41% to R26.1bn boosted by the addition of NKD.
We haven't written up this one. Moneyweb has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
Revenue jumped 41% to R26.1bn boosted by the addition of NKD.
We haven't written up this one. Moneyweb has the full story — the link below goes straight to it.
OCBC strategists Sim Moh Siong and Christopher Wong note that the Australian Dollar (AUD) has been the weakest G10 currency during recent risk aversion.
(RTTNews) - BioVersys AG (BIOV.SW) announced results from the Phase 2a ENABLE study of alpibectir in combination with ethionamide or AlpE in patients with newly diagnosed drug-sensitive pulmonary…
The company expects adjusted earnings per share to increase by up to 13.5% for the six months to 30 September.
The stock has been volatile, but its price is appealing, and its growth prospects good.